Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.930
-1.020 (-34.58%)
At close: Jan 8, 2026, 4:00 PM EST
1.920
-0.010 (-0.52%)
After-hours: Jan 8, 2026, 7:16 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $60.9 million as of January 8, 2026. Its market cap has decreased by -70.76% in one year.
Market Cap
60.90M
Enterprise Value
-33.18M
1-Year Change
-70.76%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $60.90M, a decrease of -74.10%. That is a compound annual growth rate of -34.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 93.09M | 22.41% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |